CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Tenofovir disoproxil fumarate (TDF) versus Emtricitabine plus TDF for treatment of chronic Hepatitis B (CHB) in subjects with persistent viral replication receiving Adefovir dipivoxil (ADV)
DOI 10.1055/s-0028-1089367
Bibliografische Angaben
Nachweis in CareLit
Autor:innenT Berg, B Möller, G Gerken, MC Jung, U Spengler, H Hartmann, A Snow-Lampart, D Frederick, D Oldach, J Sorbel, K Borroto-Esoda, F Rousseau
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe09/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background and aims: TDF and FTC are nucleotide/side analogues, obligatory chain terminators, with potent activity against hepatitis B virus (HBV). The primary objective of this Phase 2 study was to characterize the antiviral activity of TDF 300mg QD versus the fixed-dose combination of TDF 300mg plus FTC 200mg QD in CHB subjects with incomplete virologic response while receiving ADV 10mg QD for at least 6 months. M…
Zitieren
Zitierempfehlung
T Berg, B Möller, G Gerken, MC Jung, U Spengler, H Hartmann, A Snow-Lampart, D Frederick, D Oldach, J Sorbel, K Borroto-Esoda, F Rousseau (2008) Tenofovir disoproxil fumarate (TDF) versus Emtricitabine plus TDF for treatment of chronic Hepatitis B (CHB) in subjects with persistent viral replication receiving Adefovir dipivoxil (ADV). Zeitschrift für Gastroenterologie (09). https://doi.org/10.1055/s-0028-1089367
Mit CareLit weiterarbeiten